145 related articles for article (PubMed ID: 34918112)
21. Long-Term Outcomes of Paediatric-Onset Craniopharyngioma: A Retrospective Analysis from a Tertiary Care Centre in North India.
Harsha GS; Dabadghao P; Sudhanshu S
Neurol India; 2022; 70(2):600-605. PubMed ID: 35532626
[TBL] [Abstract][Full Text] [Related]
22. [Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood].
Thomas-Teinturier C; Salenave S
Bull Cancer; 2015; 102(7-8):612-21. PubMed ID: 25981322
[TBL] [Abstract][Full Text] [Related]
23. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics.
Brignardello E; Felicetti F; Castiglione A; Chiabotto P; Corrias A; Fagioli F; Ciccone G; Boccuzzi G
Eur J Endocrinol; 2013 Mar; 168(3):465-72. PubMed ID: 23258270
[TBL] [Abstract][Full Text] [Related]
24. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma.
Chakrabarti I; Amar AP; Couldwell W; Weiss MH
J Neurosurg; 2005 Apr; 102(4):650-7. PubMed ID: 15871507
[TBL] [Abstract][Full Text] [Related]
25. DIAGNOSING AND MONITORING ENDOCRINE DYSFUNCTION, DIABETES, AND OBESITY IN A COHORT OF ADULT SURVIVORS OF CHILDHOOD CANCER.
Hudspeth VR; Gold SH; Clemmons DR
Endocr Pract; 2017 Dec; 23(12):1394-1401. PubMed ID: 29144813
[TBL] [Abstract][Full Text] [Related]
26. The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma.
Abayomi OK; Sadeghi-Nejad A
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):945-8. PubMed ID: 3721935
[TBL] [Abstract][Full Text] [Related]
27. Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.
Zhang D; Gu M
Reprod Biol Endocrinol; 2023 Oct; 21(1):91. PubMed ID: 37794442
[TBL] [Abstract][Full Text] [Related]
28. Late endocrine sequelae after radiotherapy of pediatric brain tumors are independent of tumor location.
Rohrer TR; Beck JD; Grabenbauer GG; Fahlbusch R; Buchfelder M; Dörr HG
J Endocrinol Invest; 2009 Apr; 32(4):294-7. PubMed ID: 19636193
[TBL] [Abstract][Full Text] [Related]
29. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
Shalitin S; Laur E; Lebenthal Y; Ash S; Yaniv I; Phillip M
Horm Res Paediatr; 2014; 81(1):32-42. PubMed ID: 24246763
[TBL] [Abstract][Full Text] [Related]
30. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
31. Endocrine disorders in 66 suprasellar and pineal tumors of patients with prepubertal and pubertal ages.
Rivarola MA; Mendilaharzu H; Warman M; Belgorosky A; Iorcansky S; Castellano M; Caresana A; Chaler E; Maceiras M
Horm Res; 1992; 37(1-2):1-6. PubMed ID: 1398469
[TBL] [Abstract][Full Text] [Related]
32. Endocrine Long-Term Follow-Up of Children with Neurofibromatosis Type 1 and Optic Pathway Glioma
.
Sani I; Albanese A
Horm Res Paediatr; 2017; 87(3):179-188. PubMed ID: 28346917
[TBL] [Abstract][Full Text] [Related]
33. Endocrinological late effects of oncologic treatment on survivors of medulloblastoma.
Hidalgo Santos AD; de Mingo Alemany MDC; Moreno Macián F; León Cariñena S; Collado Ballesteros E; Cañete Nieto A
Rev Chil Pediatr; 2019 Dec; 90(6):598-605. PubMed ID: 32186582
[TBL] [Abstract][Full Text] [Related]
34. Antibodies Against Hypothalamus and Pituitary Gland in Childhood-Onset Brain Tumors and Pituitary Dysfunction.
Patti G; Calandra E; De Bellis A; Gallizia A; Crocco M; Napoli F; Allegri AME; Thiabat HF; Bellastella G; Maiorino MI; Garrè ML; Parodi S; Maghnie M; di Iorgi N
Front Endocrinol (Lausanne); 2020; 11():16. PubMed ID: 32132974
[No Abstract] [Full Text] [Related]
35. Short-term Assessment of HSCT Effects on the Hypothalamus-Pituitary Axis in Pediatric Thalassemic Patients.
Hamidieh AA; Mohseni F; Behfar M; Hamidi Z; Alimoghaddam K; Pajouhi M; Larijani B; Mohajeri-Tehrani MR; Ghavamzadeh A
Arch Iran Med; 2018 Feb; 21(2):56-60. PubMed ID: 29664655
[TBL] [Abstract][Full Text] [Related]
36. [Endocrine disorders in children after treatment for brain tumors].
Krawczuk-Rybak M
Pediatr Endocrinol Diabetes Metab; 2010; 16(2):114-8. PubMed ID: 20813089
[TBL] [Abstract][Full Text] [Related]
37. Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors.
Viswanathan V; Pradhan KR; Eugster EA
Endocr Pract; 2011; 17(6):891-6. PubMed ID: 21613054
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Outcomes of Pituitary Microadenomas in Children with Short Stature/Growth Hormone Deficiency.
Derrick KM; Gomes WA; Gensure RC
Horm Res Paediatr; 2018; 90(3):151-160. PubMed ID: 30261514
[TBL] [Abstract][Full Text] [Related]
39. Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome.
González Briceño L; Grill J; Bourdeaut F; Doz F; Beltrand J; Benabbad I; Brugières L; Dufour C; Valteau-Couanet D; Guerrini-Rousseau L; Aerts I; Orbach D; Alapetite C; Samara-Boustani D; Pinto G; Simon A; Touraine P; Sainte-Rose C; Zerah M; Puget S; Elie C; Polak M
Horm Res Paediatr; 2014; 82(6):364-71. PubMed ID: 25377653
[TBL] [Abstract][Full Text] [Related]
40. Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function.
Merchant TE; Williams T; Smith JM; Rose SR; Danish RK; Burghen GA; Kun LE; Lustig RH
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):45-50. PubMed ID: 12182973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
